May 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases of surgeries....
April 21, 2026
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are also fueling market expansion....
April 21, 2026
The HIV PrEP market is expanding due to its growing approvals as well as rising long-acting injectable PrEP innovations. North America led the market due to the early adoption of the HIV PrEP....
April 21, 2026
Market insights predict, the U.S. pharmaceutical water industry is expected to grow from USD 7.11 billion in 2024 to USD 17.04 billion by 2034, driven by a CAGR of 8.94%. Rising demand for injectable drugs, vaccines, biologics, and biosimilars, which require ultra-pure water like Water for Injection(WFI), has driven the growth of the market....
April 21, 2026
According to forecasts, the global meloxicam market will grow from USD 7.62 billion in 2024 to USD 12.23 billion by 2034, with an expected CAGR of 4.84%. The market is growing due to the increasing prevalence of inflammatory and pain-related conditions, along with rising demand for safe, effective NSAID therapies. In North America, the market domin...
April 21, 2026
Projections indicate that, birth control pills industry is projected to rise from USD 19.48 billion in 2025 to USD 30.63 billion by 2035, reflecting a CAGR of 4.63% over the next decade.The birth control pills market is expanding due to its growing innovations and approvals. North America led the market due to the growth in reproductive health awar...
April 21, 2026
Market insights predict, the Middle East and Africa pharmaceutical industry is expected to grow from USD 75.15 billion in 2024 to USD 141.3 billion by 2034, driven by a CAGR of 6.52%. This market is rising due to increasing chronic disease prevalence, growing healthcare investments, expanding local manufacturing, and improved access through digital...
April 21, 2026
Market insights predict the global Latin America pharmaceutical industry will increase from USD 91.85 billion in 2024 to USD 172.71 billion by 2034, achieving a CAGR of 6.52%. The market is expanding due to the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing demand for innovative therapies. In Latin America, Br...
April 21, 2026
The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics....
April 21, 2026
The global marine pharmaceuticals market was valued at USD 6.19 B in 2024 and is projected to reach USD 10.34 B by 2034 at a 5.29% CAGR. Covers NA, EU, APAC, LA, MEA, with full segmentation, trade, manufacturer, and supplier data. Regional data across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa is presente...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
